Mejora resultado LH recidivado refractario
-
Upload
santiago-nieto-fernandez -
Category
Health & Medicine
-
view
129 -
download
1
Transcript of Mejora resultado LH recidivado refractario
Improving Therapy Outcomes in Relapsed/Refractory Hodgkin Lymphoma
Program Objectives
Brentuximab Vedotin in Hodgkin Lymphoma
Brentuximab Vedotin in Patients With R/R HL
Brentuximab Vedotin: Adverse Events
Nivolumab in Relapsed/Refractory HL
Pembrolizumab in Relapsed/Refractory HL
Checkpoint Inhibitors: Adverse Events
AETHERA Study: Brentuximab as Consolidation Therapy After ASCT
Ongoing Trials with Brentuximab Vedotin and Checkpoint Inhibitors in HL
Educating and Communicating With Patient With HL
Salvage Therapy With Brentuximab Followed By Chemotherapy
Brentuximab + AVD vs ABVD in Advanced Stage HL
Survivorship in Patients With HL
Encouraging Shared Decision Making With Patients
Abbreviations
Abbreviations (cont)
References
References (cont)
References (cont)
References (cont)